1.Preliminary discussion on the preparation of medical device standards adopting international standards.
Chinese Journal of Medical Instrumentation 2012;36(3):215-217
Conclude some specific problems in drafting the industry standards of medical devices which are adopted to international standards. Provide relevant suggestion and recommendation in accordance to GB/T 1.1-2009 and GB/T 20000.2-2009, some preliminary suggestions were accordingly proposed.
Device Approval
;
standards
;
International Cooperation
3.Aimins at Reasonable Inventory Control of Medical Materials
Tazuko SATO ; Teiko MIURA ; Minako WATANABE ; Masaya OKUYAMA ; Nagao TOMAE ; Toshihiko HOSHINA ; Tamaki SAITO
Journal of the Japanese Association of Rural Medicine 2007;56(1):29-33
Sound management of hospital in Japan in general has become more and more difficult with frequent reductions in the fees officially paid to medical institutions for medical examinations and treatments, and this current situation obviously necessitates a more efficient way of hospital management and ardent efforts at improvement on the part of our hospital as well. The Division on Nursing has set the goals to implement thoroughgoing cost-management strategies and to strengthen cooperation with other divisions. For this purpose we visited the hospital wards jointly with other personnel from the Divisions of Medical Materials and Dispensary to check inventories of medical materials and to make them optimum. As a result, it was found that medical materials were often improperly placed, stored excessively, or returned inaccurately. The instructions for redefining the proper quota of the medical materials per ward, putting them in order and returning them properly in case of excess facilitated direct communication and cooperation between divisions, and resulted in inventory reduction and thus the annual costs of returning them. These efforts successfully inspired each staff member to participate voluntarily in the management of our hospital, which eventually led to reasonable inventory control of medical materials. It would be important for each division, while demonstrating its specialty, to realize the importance of cooperation to reach far greater achievements.
Hospitals
;
Materials
;
seconds
;
cooperation
;
Medical
8.Sharing Clinical Trial Data: A Proposal from the International Committee of Medical Journal Editors.
Darren B TAICHMAN ; Joyce BACKUS ; Christopher BAETHGE ; Howard BAUCHNER ; Peter W de LEEUW ; Jeffrey M DRAZEN ; John FLETCHER ; Frank FRIZELLE ; Trish GROVES ; Abraham HAILEAMLAK ; Astrid JAMES ; Christine LAINE ; Larry PEIPERL ; Anja PINBORG ; Peush SAHNI ; Si-Nan WU
Chinese Medical Journal 2016;129(2):127-128
10.Bridging the US and China together to conquer cancer: report of the 4th annual meeting of the US Chinese Anti-Cancer Association (USCACA).
Chinese Journal of Cancer 2012;31(7):315-318
A global collaborative effort is pivotal to conquer cancer. Themed "Emerging role of China in global clinical development of novel anti-cancer drugs", the US Chinese Anti-Cancer Association (USCACA) held its 4th annual meeting in Chicago on June 2, 2012, in conjunction with the American Society of Clinical Oncology (ASCO) annual meeting to further bridge the US and China together to outsmart cancer. Although a young organization, USCACA has made significant contributions to this goal in the 3 years since its inception through extensive collaboration with academic organizations, the pharmaceutical industry, and governmental agencies. USCACA has engaged various stakeholders in developing translational and personalized medical strategies to facilitate new anti-cancer drug development and clinical trials in China. USCACA has initiated and implemented the USCACA-National Foundation for Cancer Research (NFCR) scholarship to encourage overseas returnees to continue cancer research in China. USCACA announced the Hengrui-USCACA scholarship to fund clinical trial staff from China to conduct the observation of early oncologic clinical trials in the US. During the annual meeting, distinguished panelists and the audience discussed the following critical topics:(1) oncologic translational research and early development capabilities in China;(2) novel chemical entity development and partnership with Chinese companies; and (3) Chinese participation in global anti-cancer drug development. USCACA will continue to promote collaborations among cancer researchers and clinicians in the US and China by engaging in more frequent communications and joint efforts across fields, disciplines, and countries, diligently working together toward curing and eliminating cancers.
Chicago
;
China
;
International Cooperation
;
Medical Oncology
;
Societies, Medical
;
United States